LogoThe NeuroCircuit
About
HackTheNeuron
Recommendations
Subscribe
Upgrade
Oliver Buchannon
Ricardo Albornoz

Computer Scientist & IT Analyst exploring neurotech, BCIs, and the future of human-computer synergy.

Clinical Trial News

+3

Weekly Signal: 55 |  CorTec Enters FDA's TAP for Chronic BCIs

Apr 25, 2026

•

2 min read

Weekly Signal: 55 | CorTec Enters FDA's TAP for Chronic BCIs

Plus €40.6M and a stealth exit

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Apr 18, 2026

•

2 min read

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Invasiveness tiers get crowded

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 53 | CorTec Closes the BCI Loop

Apr 11, 2026

•

8 min read

Weekly Signal: 53 | CorTec Closes the BCI Loop

Plus: organoids go to war

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+6

Weekly Signal: 52 |  The Signal Everyone Used Was Wrong

Apr 4, 2026

•

9 min read

Weekly Signal: 52 | The Signal Everyone Used Was Wrong

Plus: living-neuron BCIs get a surgeon

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 51 | When the Brain Overcorrects

Mar 28, 2026

•

6 min read

Weekly Signal: 51 | When the Brain Overcorrects

Control, not just signal

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 50 | The Typing Threshold

Mar 21, 2026

•

14 min read

Weekly Signal: 50 | The Typing Threshold

BCIs Close in on Normal Speed

Ricardo Albornoz
Ricardo Albornoz

Ethics & Policy

+6

Weekly Signal: 49 | China Wins the BCI Commercial Race

Mar 14, 2026

•

14 min read

Weekly Signal: 49 | China Wins the BCI Commercial Race

The Regulatory Finish Line Just Moved

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 48 | BCIs Race to First Commercial Products

Mar 8, 2026

•

16 min read

Weekly Signal: 48 | BCIs Race to First Commercial Products

Science Corp. Leads the Pack

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+7

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Mar 1, 2026

•

12 min read

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Plus: Japan's Stem Cell Gamble

Ricardo Albornoz
Ricardo Albornoz

Neuroscience

+5

Weekly Signal: 46 | Forecasting Alzheimer's and Fixing EEG's Data Problem

Feb 21, 2026

•

7 min read

Weekly Signal: 46 | Forecasting Alzheimer's and Fixing EEG's Data Problem

Forecasting the Brain's Future

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 45 | Clinical Signals in Brain Interfaces

Feb 15, 2026

•

6 min read

Weekly Signal: 45 | Clinical Signals in Brain Interfaces

Real-World Decoding Advances

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 44 | BCI Rehab Evidence Comes Into Focus

Feb 8, 2026

•

7 min read

Weekly Signal: 44 | BCI Rehab Evidence Comes Into Focus

Poststroke outcomes, coverage signals

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 43 | Durability Replaces Demos in Neurotech

Feb 1, 2026

•

6 min read

Weekly Signal: 43 | Durability Replaces Demos in Neurotech

Long-horizon signals emerge

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+4

Weekly Signal: 42 | Neurotech Advances—Military Stakes Rise

Jan 24, 2026

•

6 min read

Weekly Signal: 42 | Neurotech Advances—Military Stakes Rise

Trials, implants, oversight

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+6

Weekly Signal: 41 | Evidence Tightens Across Neurotechnology

Jan 17, 2026

•

7 min read

Weekly Signal: 41 | Evidence Tightens Across Neurotechnology

Trials, Funding, FDA Signals

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 40 | The First Signal of 2026

Jan 11, 2026

•

7 min read

Weekly Signal: 40 | The First Signal of 2026

Foundations, funding, and clarity

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 39 | Clinical Proof, Clearer Signals

Dec 27, 2025

•

4 min read

Weekly Signal: 39 | Clinical Proof, Clearer Signals

Neuromodulation and measurement advance

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 38 | When BCIs Leave the Lab

Dec 20, 2025

•

6 min read

Weekly Signal: 38 | When BCIs Leave the Lab

Regulation, reality, deployment

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+7

Weekly Signal: 37 | Neurotech Moves Home and Wireless

Dec 13, 2025

•

8 min read

Weekly Signal: 37 | Neurotech Moves Home and Wireless

BCIs, Stimulation, and Scale

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 36 | ALS Trials Accelerate, Ultrasound Advances, MRI Goes Bedside

Dec 6, 2025

•

7 min read

Weekly Signal: 36 | ALS Trials Accelerate, Ultrasound Advances, MRI Goes Bedside

Critical milestones in modern neurotech

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Nov 29, 2025

•

7 min read

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Breakthroughs in Brain Signals and Safety

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+4

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Nov 22, 2025

•

6 min read

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Signals shaping neurotech’s future

Ricardo Albornoz
Ricardo Albornoz

Ethics & Policy

+5

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Nov 15, 2025

•

7 min read

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Decoding, biomarkers, and governance

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 32 | Tiny Implants, Big Governance

Nov 8, 2025

•

5 min read

Weekly Signal: 32 | Tiny Implants, Big Governance

Miniaturized BCIs & Global Neuro-Ethics

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Nov 1, 2025

•

7 min read

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Clinical data, funding moves, and policy shifts

Ricardo Albornoz
Ricardo Albornoz
Load more
The NeuroCircuit

The NeuroCircuit

The weekly briefing on neurotech for people building the future of the brain.


FAQs

NeuroCircuit

HackTheNeuron

© 2026 The NeuroCircuit.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv